141 related articles for article (PubMed ID: 14687465)
1. Impact of acute vivax malaria on the immune system and viral load of HIV-positive subjects.
Chen X; Xiao B; Shi W; Xu H; Gao K; Rao J; Zhang Z
Chin Med J (Engl); 2003 Dec; 116(12):1810-20. PubMed ID: 14687465
[TBL] [Abstract][Full Text] [Related]
2. Procedure and clinical assessments of malariotherapy: recent experience in 20 HIV patients.
Chen X; Xiao B; Xu H; Shi W; Gao K; Rao J
Chin Med J (Engl); 2003 Jul; 116(7):1016-21. PubMed ID: 12890375
[TBL] [Abstract][Full Text] [Related]
3. Changes in HIV RNA viral load, CD4+ T-cell counts, and levels of immune activation markers associated with anti-tuberculosis therapy and cotrimoxazole prophylaxis among HIV-infected tuberculosis patients in Abidjan, Cote d'Ivoire.
Kalou M; Sassan-Morokro M; Abouya L; Bile C; Maurice C; Maran M; Tossou O; Roels T; Greenberg AE; Wiktor SZ; Nkengasong JN
J Med Virol; 2005 Feb; 75(2):202-8. PubMed ID: 15602734
[TBL] [Abstract][Full Text] [Related]
4. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
[TBL] [Abstract][Full Text] [Related]
5. Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial.
Hurwitz BE; Klaus JR; Llabre MM; Gonzalez A; Lawrence PJ; Maher KJ; Greeson JM; Baum MK; Shor-Posner G; Skyler JS; Schneiderman N
Arch Intern Med; 2007 Jan; 167(2):148-54. PubMed ID: 17242315
[TBL] [Abstract][Full Text] [Related]
6. Phase-1 studies of malariotherapy for HIV infecton.
Chen X; Heimlich HJ; Xiao B; Liu S; Lu Y; Rao J; Spletzer EG
Chin Med Sci J; 1999 Dec; 14(4):224-8. PubMed ID: 12894896
[TBL] [Abstract][Full Text] [Related]
7. Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy.
Lim A; Tan D; Price P; Kamarulzaman A; Tan HY; James I; French MA
AIDS; 2007 Jul; 21(12):1525-34. PubMed ID: 17630546
[TBL] [Abstract][Full Text] [Related]
8. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
[TBL] [Abstract][Full Text] [Related]
9. Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults.
Erikstrup C; Kallestrup P; Zinyama-Gutsire RB; Gomo E; Butterworth AE; Pedersen BK; Ostrowski SR; Gerstoft J; Ullum H
AIDS; 2007 Nov; 21(17):2283-91. PubMed ID: 18090276
[TBL] [Abstract][Full Text] [Related]
10. Cytokine profile in human immunodeficiency virus positive patients with and without tuberculosis.
Agarwal SK; Singh A; Anuradha S; Singh NP; Sokhi J; Baveja UK
J Assoc Physicians India; 2001 Aug; 49():799-802. PubMed ID: 11837467
[TBL] [Abstract][Full Text] [Related]
11. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms involved in the low-level regeneration of CD4+ cells in HIV-1-infected patients receiving highly active antiretroviral therapy who have prolonged undetectable plasma viral loads.
Benveniste O; Flahault A; Rollot F; Elbim C; Estaquier J; Pédron B; Duval X; Dereuddre-Bosquet N; Clayette P; Sterkers G; Simon A; Ameisen JC; Leport C
J Infect Dis; 2005 May; 191(10):1670-9. PubMed ID: 15838794
[TBL] [Abstract][Full Text] [Related]
13. Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000).
Reading C; Dowding C; Schramm B; Garsd A; Onizuka-Handa N; Stickney D; Frincke J
Clin Microbiol Infect; 2006 Nov; 12(11):1082-8. PubMed ID: 17002607
[TBL] [Abstract][Full Text] [Related]
14. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
[TBL] [Abstract][Full Text] [Related]
15. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
[TBL] [Abstract][Full Text] [Related]
16. Stability of plasma levels of cytokines and soluble activation markers in patients with human immunodeficiency virus infection.
Aziz N; Nishanian P; Taylor JM; Mitsuyasu RT; Jacobson JM; Dezube BJ; Lederman MM; Detels R; Fahey JL
J Infect Dis; 1999 Apr; 179(4):843-8. PubMed ID: 10068579
[TBL] [Abstract][Full Text] [Related]
17. Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
Plana M; Ferrer E; Martínez C; Podzamczer D; García F; Maleno MJ; Barceló JJ; García A; Barberá MJ; Lacarcel M; Miró JM; Gallart T; Gatell JM
Antivir Ther; 2004 Apr; 9(2):197-204. PubMed ID: 15134181
[TBL] [Abstract][Full Text] [Related]
18. Cytokine expression during syphilis infection in HIV-1-infected individuals.
Knudsen A; Benfield T; Kofoed K
Sex Transm Dis; 2009 May; 36(5):300-4. PubMed ID: 19265730
[TBL] [Abstract][Full Text] [Related]
19. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 years of follow-up.
Resino S; Resino R; Micheloud D; Gurbindo Gutiérrez D; Léon JA; Ramos JT; Ciria L; de José I; Mellado J; Muñoz-Fernández A;
Clin Infect Dis; 2006 Mar; 42(6):862-9. PubMed ID: 16477566
[TBL] [Abstract][Full Text] [Related]
20. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Moore RD; Keruly JC
Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
